Skip to main content
Top
Published in: Clinical Sarcoma Research 1/2017

Open Access 01-12-2017 | Case report

Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

Authors: K. Behi, M. Ayadi, E. Mezni, K. Meddeb, A. Mokrani, Y. Yahyaoui, F. Ksontini, H. Rais, N. Chrait, A. Mezlini

Published in: Clinical Sarcoma Research | Issue 1/2017

Login to get access

Abstract

Background

Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases.

Case presentation

a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence.

Conclusions

Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
Literature
1.
go back to reference Smith S, Grange S, Wilson P. Leiomyosarcoma of the left atrium. A case study. Radiography. 2012;18(3):225–8.CrossRef Smith S, Grange S, Wilson P. Leiomyosarcoma of the left atrium. A case study. Radiography. 2012;18(3):225–8.CrossRef
2.
go back to reference Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, et al. Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group 1990. Eur J Cancer Oxf Engl. 2014;50(1):128–36.CrossRef Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, et al. Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group 1990. Eur J Cancer Oxf Engl. 2014;50(1):128–36.CrossRef
3.
4.
go back to reference Wang J-G, Cui L, Jiang T, Li Y-J, Wei Z-M. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns. Asian Cardiovasc Thorac Ann. 2015;23(5):623–30.CrossRefPubMed Wang J-G, Cui L, Jiang T, Li Y-J, Wei Z-M. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns. Asian Cardiovasc Thorac Ann. 2015;23(5):623–30.CrossRefPubMed
5.
go back to reference Galeone A, Validire P, Debrosse D, Folliguet T, Laborde F. Leiomyosarcoma of the right inferior pulmonary vein: 2 years survival with multimodality therapy. Gen Thorac Cardiovasc Surg. 2013;61(9):534–7.CrossRefPubMed Galeone A, Validire P, Debrosse D, Folliguet T, Laborde F. Leiomyosarcoma of the right inferior pulmonary vein: 2 years survival with multimodality therapy. Gen Thorac Cardiovasc Surg. 2013;61(9):534–7.CrossRefPubMed
7.
go back to reference Lv Y, Pang X, Zhang Q, Jia D. Cardial leiomyosarcoma with multiple lesions involved: a case report. Int J Clin Exp Pathol. 2015;8(11):15412–6.PubMedPubMedCentral Lv Y, Pang X, Zhang Q, Jia D. Cardial leiomyosarcoma with multiple lesions involved: a case report. Int J Clin Exp Pathol. 2015;8(11):15412–6.PubMedPubMedCentral
8.
go back to reference Kornberg A, Wildhirt SM, Kreuzer E, Reichart B. Asymptomatic right atrial leiomyosarcoma with tricuspid valve obstruction in a young female patient. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio Thorac Surg. 1998;14:635–8.CrossRef Kornberg A, Wildhirt SM, Kreuzer E, Reichart B. Asymptomatic right atrial leiomyosarcoma with tricuspid valve obstruction in a young female patient. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio Thorac Surg. 1998;14:635–8.CrossRef
9.
go back to reference Takamizawa S, Sugimoto K, Tanaka H, Sakai O, Arai T, Saitoh A. A case of primary leiomyosarcoma of the heart. Intern Med Tokyo Jpn. 1992;31:265–8.CrossRef Takamizawa S, Sugimoto K, Tanaka H, Sakai O, Arai T, Saitoh A. A case of primary leiomyosarcoma of the heart. Intern Med Tokyo Jpn. 1992;31:265–8.CrossRef
10.
go back to reference Fox JP, Freitas E, McGiffin DC, Firouz-Abadi AA, West MJ. Primary leiomyosarcoma of the heart: a rare cause of obstruction of the left ventricular outflow tract. Aust N Z J Med. 1991;21:881–3.CrossRefPubMed Fox JP, Freitas E, McGiffin DC, Firouz-Abadi AA, West MJ. Primary leiomyosarcoma of the heart: a rare cause of obstruction of the left ventricular outflow tract. Aust N Z J Med. 1991;21:881–3.CrossRefPubMed
12.
go back to reference Minakata K, Konishi Y, Matsumoto M, Nonaka M, Yamada N. Primary leiomyosarcoma of the left atrium. Jpn Circ J. 1999;63:414–5.CrossRefPubMed Minakata K, Konishi Y, Matsumoto M, Nonaka M, Yamada N. Primary leiomyosarcoma of the left atrium. Jpn Circ J. 1999;63:414–5.CrossRefPubMed
14.
go back to reference Minardi G, Pulignano G, Sentinelli S, Narducci C, Giovannini M. Left atrial leiomyosarcoma: double occurrence and double recurrence—report of one case. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 1998;11:1171–6.CrossRef Minardi G, Pulignano G, Sentinelli S, Narducci C, Giovannini M. Left atrial leiomyosarcoma: double occurrence and double recurrence—report of one case. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 1998;11:1171–6.CrossRef
15.
go back to reference Burnett RA. Primary cardiac leiomyosarcoma with pulmonary metastases: a diagnostic problem. Scott Med J. 1975;20:125–8.CrossRefPubMed Burnett RA. Primary cardiac leiomyosarcoma with pulmonary metastases: a diagnostic problem. Scott Med J. 1975;20:125–8.CrossRefPubMed
16.
17.
go back to reference Ogimoto A, Hamada M, Ohtsuka T, Hara Y, Shigematsu Y, Yokoyama A, et al. Rapid progression of primary cardiac leiomyosarcoma with obstruction of the left ventricular outflow tract and mitral stenosis. Intern Med Tokyo Jpn. 2003;42:827–30.CrossRef Ogimoto A, Hamada M, Ohtsuka T, Hara Y, Shigematsu Y, Yokoyama A, et al. Rapid progression of primary cardiac leiomyosarcoma with obstruction of the left ventricular outflow tract and mitral stenosis. Intern Med Tokyo Jpn. 2003;42:827–30.CrossRef
18.
go back to reference Willaert W, Claessens P, Shoja A, Heremans A, Deferm H, Roelandts J, et al. Ventricular outflow tract obstruction secondary to leiomyosarcoma of the right ventricle. Jpn Heart J. 2001;42:377–86.CrossRefPubMed Willaert W, Claessens P, Shoja A, Heremans A, Deferm H, Roelandts J, et al. Ventricular outflow tract obstruction secondary to leiomyosarcoma of the right ventricle. Jpn Heart J. 2001;42:377–86.CrossRefPubMed
19.
go back to reference Strina C, Zannoni M, Parolin V, Cetto GL, Zuliani S. Bone metastases from primary cardiac sarcoma: case report. Tumori. 2009;95:251–3.PubMed Strina C, Zannoni M, Parolin V, Cetto GL, Zuliani S. Bone metastases from primary cardiac sarcoma: case report. Tumori. 2009;95:251–3.PubMed
20.
go back to reference Lee SH, Kim WH, Choi JB, Lee SR, Rhee KS, Chae JK, et al. Huge primary pleomorphic leiomyosarcoma in the right ventricle with impending obstruction of both inflow and outflow tracts. Circ J Off J Jpn Circ Soc. 2009;73:779–82. Lee SH, Kim WH, Choi JB, Lee SR, Rhee KS, Chae JK, et al. Huge primary pleomorphic leiomyosarcoma in the right ventricle with impending obstruction of both inflow and outflow tracts. Circ J Off J Jpn Circ Soc. 2009;73:779–82.
25.
go back to reference Astarcioglu MA. Multimodality imaging of a recurrent case of right-sided cardiac leiomyosarcoma with an unusual clinical course. Turk Kardiyol Dernegi Arsivi Arch Turk Soc Cardiol. 2016. doi:10.5543/tkda.2015.09125. Astarcioglu MA. Multimodality imaging of a recurrent case of right-sided cardiac leiomyosarcoma with an unusual clinical course. Turk Kardiyol Dernegi Arsivi Arch Turk Soc Cardiol. 2016. doi:10.​5543/​tkda.​2015.​09125.
27.
go back to reference Nakanishi H, Furukawa K, Noguchi R, Furutachi A, Itoh M, Kamohara K, et al. Primary cardiac leiomyosarcoma originating from the left atrium. Kyobu Geka. 2012;65:1057–61.PubMed Nakanishi H, Furukawa K, Noguchi R, Furutachi A, Itoh M, Kamohara K, et al. Primary cardiac leiomyosarcoma originating from the left atrium. Kyobu Geka. 2012;65:1057–61.PubMed
28.
31.
go back to reference Esaki M, Kagawa K, Noda T, Nishigaki K, Gotoh K, Fujiwara H, et al. Primary cardiac leiomyosarcoma growing rapidly and causing right ventricular outflow obstruction. Intern Med Tokyo Jpn. 1998;37:370–5.CrossRef Esaki M, Kagawa K, Noda T, Nishigaki K, Gotoh K, Fujiwara H, et al. Primary cardiac leiomyosarcoma growing rapidly and causing right ventricular outflow obstruction. Intern Med Tokyo Jpn. 1998;37:370–5.CrossRef
32.
go back to reference Guschmann M, Hofmeister J. Primary leiomyosarcoma in the left atrium—a rarity. Case report and literature review. J Pathol. 1997;18:474–9.CrossRef Guschmann M, Hofmeister J. Primary leiomyosarcoma in the left atrium—a rarity. Case report and literature review. J Pathol. 1997;18:474–9.CrossRef
35.
go back to reference Pessotto R, Silvestre G, Luciani GB, Anselmi M, Pasini F, Santini F, et al. Primary cardiac leiomyosarcoma: seven-year survival with combined surgical and adjuvant therapy. Int J Cardiol. 1997;60:91–4.CrossRefPubMed Pessotto R, Silvestre G, Luciani GB, Anselmi M, Pasini F, Santini F, et al. Primary cardiac leiomyosarcoma: seven-year survival with combined surgical and adjuvant therapy. Int J Cardiol. 1997;60:91–4.CrossRefPubMed
36.
go back to reference Lo FL, Chou YH, Tiu CM, Lan GY, Hwang JH, Chern MS, et al. Primary cardiac leiomyosarcoma: imaging with 2-D echocardiography, electron beam CT and 1.5-Tesla MR. Eur J Radiol. 1998;27:72–6.CrossRefPubMed Lo FL, Chou YH, Tiu CM, Lan GY, Hwang JH, Chern MS, et al. Primary cardiac leiomyosarcoma: imaging with 2-D echocardiography, electron beam CT and 1.5-Tesla MR. Eur J Radiol. 1998;27:72–6.CrossRefPubMed
Metadata
Title
Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
Authors
K. Behi
M. Ayadi
E. Mezni
K. Meddeb
A. Mokrani
Y. Yahyaoui
F. Ksontini
H. Rais
N. Chrait
A. Mezlini
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Clinical Sarcoma Research / Issue 1/2017
Electronic ISSN: 2045-3329
DOI
https://doi.org/10.1186/s13569-017-0069-3

Other articles of this Issue 1/2017

Clinical Sarcoma Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine